What's in Colgate Palmolive's pipeline?

Colgate Palmolive has 13 drugs in our index: 12 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Colgate Palmolive's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/colgate-palmolive.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

Colgate Palmolive — Portfolio Competitive Intelligence Brief

Colgate Palmolive pipeline: 12 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

12 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Total Flavor option 1	Total Flavor option 1	marketed	Flavoring agent	Taste buds and olfactory receptors	Other
Fluoride	Fluoride	marketed			Other
Control product	Control product	marketed
Total Flavor option 2	Total Flavor option 2	marketed
0.76% sodium monofluorophosphate	0.76% sodium monofluorophosphate	marketed
Triclosan Containing Toothpaste	Triclosan Containing Toothpaste	marketed
Parodontax toothpaste	Parodontax toothpaste	marketed
Sensodyne Extra Whitening	Sensodyne Extra Whitening	marketed
fluoride only toothpaste	fluoride only toothpaste	marketed
Fluoride only mouthwash	Fluoride only mouthwash	marketed
Triclosan, Fluoride	Triclosan, Fluoride	marketed
Fluoride and triclosan	Fluoride and triclosan	marketed

Therapeutic area mix

Other · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Colgate Palmolive:

Cite this brief

Drug Landscape (2026). Colgate Palmolive — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/colgate-palmolive. Accessed 2026-05-13.